Usefulness of contrast-enhanced intraoperative ultrasound using sonazoid in patients with hepatocellular carcinoma

Annals of Surgery

Volumn 254, Issue 6, 2011, Pages 992-999

  Arita, Junichi ^a   Takahashi, Michiro ^a   Hata, Shojiro ^a   Shindoh, Junichi ^a   Beck, Yoshifumi ^a   Sugawara, Yasuhiko ^a   Hasegawa, Kiyoshi ^a   Kokudo, Norihiro ^a  

^a Artificial Organ and Transplantation Division   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUBUTANE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LAPAROTOMY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE ECHOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FERRIC COMPOUNDS; HUMANS; INTRAOPERATIVE PERIOD; IRON; KUPFFER CELLS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; OXIDES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 81855170302     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822518be     Document Type: Article

References (49)

1. Makuuchi M, Hasegawa H, Yamazaki S. Intraoperative ultrasonic examination for hepatectomy. Ultrasound Med Biol. 1983;2(suppl):493-497.
2. Bismuth H, Castaing D, Garden OJ. The use of operative ultrasound in surgery of primary liver tumors. World J Surg. 1987;11:610-614.
3. Kokudo N, Imamura H, Sano K, et al. Ultrasonically assisted retrohepatic dissection for a liver hanging maneuver. Ann Surg. 2005;242:651-654.
4. Torzilli G, Montorsi M, Del Fabbro D, et al. Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence. Br J Surg. 2006;93:1238-1246.
5. Ellsmere J, Kane R, Grinbaum R, et al. Intraoperative ultrasonography during planned liver resections: why are we still performing it?. Surg Endosc. 2007;21:1280-1283.
6. Zhang K, Kokudo N, Hasegawa K, et al. Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma. Arch Surg. 2007;142:1170-1175.
7. Kokudo N, Bandai Y, Imanishi H, et al. Management of new hepatic nodules detected by intraoperative ultrasonography during hepatic resection for hepatocellular carcinoma. Surgery. 1996;119:634-640.
8. Takigawa Y, Sugawara Y, Yamamoto J, et al. New lesions detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma. Ultrasound Med Biol. 2001;27:151-156.
9. Torzilli G, Palmisano A, Del Fabbro D, et al. Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless?. A prospective cohort study of our experience. Ann Surg Oncol. 2007;14:1347-1355.
10. Bru C, Maroto A, Bruix J, et al. Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma. Dig Dis Sci. 1989;34:1765-1769.
11. Caturelli E, Solmi L, Anti M, et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut. 2004;53:1356-1362.
12. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97-104.
13. Shuto T, Yamamoto T, Tanaka S, et al. Resection of needle-tract implantation after percutaneous puncture for hepatocellular carcinoma. J Gastroenterol. 2004;39:907-908.
14. Ebara M. Complications of fine needle biopsy for focal liver lesions. Hepatol Res. 2005;31:3-4.
15. Silva MA, Hegab B, Hyde C, et al. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut. 2008;57:1592-1596.
16. Young AL, Malik HZ, Abu-Hilal M, et al. Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg. 2007;205:453-462.
17. Lu Q, Luo Y, Yuan CX, et al. Value of contrast-enhanced intraoperative ultrasound for cirrhotic patients with hepatocellular carcinoma: a report of 20 cases. World J Gastroenterol. 2008;14:4005-4010.
18. Luo W, Numata K, Morimoto M, et al. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT. Radiology. 2009;251:287-295.
19. Nakano H, Ishida Y, Hatakeyama T, et al. Contrast-enhanced intraoperative ultrasonography equippedwith lateKupffer-phase image obtained by sonazoid in patientswith colorectal livermetastases. World JGastroenterol. 2008;14:3207-3211.
20. Kindberg GM, Tolleshaug H, Roos N, et al. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res. 2003;312:49-54.
21. Watanabe R, Matsumura M, Munemasa T, et al. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol. 2007;42:643-651.
22. Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007;33:318-325.
23. Luo W, Numata K, Morimoto M, et al. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions. Eur J Radiol. 2009;72:425-431.
24. Korenaga K, Korenaga M, Furukawa M, et al. Usefulness of Sonazoid contrastenhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2009;44:733-741.
25. Numata K, Morimoto M, Ogura T, et al. Ablation therapy guided by contrastenhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med. 2008;27:395-406.
26. Inoue T, Kudo M, Hatanaka K, et al. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Oncology. 2008;75(suppl 1):48-54.
27. Yang H, Liu GJ, Lu MD, et al. Evaluation of the vascular architecture of hepatocellular carcinoma by micro flow imaging: pathologic correlation. J Ultrasound Med. 2007;26:461-467.
28. Watanabe R, MatsumuraM, Chen CJ, et al. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. Biol Pharm Bull. 2003;26:1272-1277.
29. Kudo M. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology. 2008;75(suppl 1):1-12.
30. Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology. 1999;30:889-893.
31. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983-993.
32. Liu GJ, Xu HX, Lu MD, et al. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol. 2007;80: 321-330.
33. Arita J, Hasegawa K, Takahashi M, et al. Correlation between contrast enhanced intraoperative ultrasound using Sonazoid and histological grade of resected hepatocellular carcinomas. AJR Am J Roentgenol. 2011;196:1314-1321.
34. Tanaka M, Nakashima O, Wada Y, et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology. 1996;24:807-812.
35. Lim JH, Choi D, Cho SK, et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology. 2001;220:669-676.
36. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32:205-212.
37. Suzuki S, Iijima H, Moriyasu F, et al. Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: comparative study with SPIO-MRI. Hepatol Res. 2004;29:122-126.
38. Nicolau C, Vilana R, Catala V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol. 2006;186:158-167.
39. Inoue T, Kudo M, Maenishi O, et al. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma. AJR Am J Roentgenol. 2009;192: 698-705.
40. Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol. 2009;44(suppl 19):112-118.
41. Dai Y, ChenMH, Yin SS, et al. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?. Invest Radiol. 2007;42:596-603.
42. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology. 2004;232:420-430.
43. Kamiyama N, Moriyasu F, Mine Y, et al. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol. 1999;25:411-420.
44. Hatanaka K, Kudo M, Minami Y, et al. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; 75(suppl 1):42-47.
45. Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology. 2008;51(suppl 1):61-69.
46. Kogita S, Imai Y, Okada M, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol. 2010; 20(10):2405-2413.
47. Ichikawa T, Saito K, Yoshioka N, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrastenhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010;45(3):133-141.
48. Sakamoto M, Hirohashi S. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. Jpn J Clin Oncol. 1998;28:604-608.
49. Marin D, DiMartinoM, Guerrisi A, et al. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology. 2009;251(1): 85-95.